Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment

Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven's Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with do...

Full description

Saved in:
Bibliographic Details
Published in:Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 2017, 15(3), , pp.243-247
Main Authors: Yoshino, Yuta, Mori, Takaaki, Yoshida, Taku, Toyota, Yasutaka, Shimizu, Hideaki, Iga, Jun-Ichi, Nishitani, Shusaku, Ueno, Shu-Ichi
Format: Article
Language:English
Subjects:
Original
정신과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3
cites cdi_FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3
container_end_page 247
container_issue 3
container_start_page 243
container_title Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
container_volume 15
creator Yoshino, Yuta
Mori, Takaaki
Yoshida, Taku
Toyota, Yasutaka
Shimizu, Hideaki
Iga, Jun-Ichi
Nishitani, Shusaku
Ueno, Shu-Ichi
description Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven's Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil. Twenty-one DLB patients (mean age, 78.7±4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil. There were significant improvements of RCPM in the total scores between one year donepezil treatment ( =0.013), in both Set A score ( =0.002) and Set AB score ( =0.015), but trend in the Set B score ( =0.083). Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment.
doi_str_mv 10.9758/cpn.2017.15.3.243
format article
fullrecord <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_2648840</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1927307408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3</originalsourceid><addsrcrecordid>eNpVkd9u0zAUxi0EYtXYA3CDfAdcJPhv7NwglY5BpSLQVLi1HMfZzBI7s9NO5RH21HPbMYFl6UjnfN_vHOkD4DVGZS24_GBGXxKERYl5SUvC6DMwI6imBaNEPAczLKgsMJLyBJyl9BvlR-uK1fQlOCFSSFpTOgP3y2GMYWsH6ycYOvjLpU0o0qgnp3t4sfFmcsHDeUo2_xY2O3ipt9a_TXAR-hBz60cMVzFP3dbCb3qKztgEnYfnB6jT8M5N13Bl73bwU2hdHmbIefB2tH9cD9fR6mmvfAVedLpP9uyxnoKfF5_Xi6_F6vuX5WK-KgyjdCo6gyin2GDGMGlsWxHBMKUN560VxPJaNF1VVTUmGudeixpuJcENwp0URLf0FLw_cn3s1I1xKmh3qFdB3UQ1v1wvFamYlAxl7cejdtw0g21NPjPqXo3RDTruDs7_J95dZ85WcV5xJEkGvHsExHC7sWlSg0vG9r32NmySwjURFAmGZJbio9TEkFK03dMajNQ-cpUjV_vIFeaKqhx59rz5974nx9-A6QO7rKnw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1927307408</pqid></control><display><type>article</type><title>Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment</title><source>Freely Accessible Science Journals</source><source>PubMed Central</source><creator>Yoshino, Yuta ; Mori, Takaaki ; Yoshida, Taku ; Toyota, Yasutaka ; Shimizu, Hideaki ; Iga, Jun-Ichi ; Nishitani, Shusaku ; Ueno, Shu-Ichi</creator><creatorcontrib>Yoshino, Yuta ; Mori, Takaaki ; Yoshida, Taku ; Toyota, Yasutaka ; Shimizu, Hideaki ; Iga, Jun-Ichi ; Nishitani, Shusaku ; Ueno, Shu-Ichi</creatorcontrib><description>Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven's Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil. Twenty-one DLB patients (mean age, 78.7±4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil. There were significant improvements of RCPM in the total scores between one year donepezil treatment ( =0.013), in both Set A score ( =0.002) and Set AB score ( =0.015), but trend in the Set B score ( =0.083). Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment.</description><identifier>ISSN: 1738-1088</identifier><identifier>EISSN: 2093-4327</identifier><identifier>DOI: 10.9758/cpn.2017.15.3.243</identifier><identifier>PMID: 28783933</identifier><language>eng</language><publisher>Korea (South): Korean College of Neuropsychopharmacology</publisher><subject>Original ; 정신과학</subject><ispartof>Clinical Psychopharmacology and Neuroscience, 2017, 15(3), , pp.243-247</ispartof><rights>Copyright © 2017, Korean College of Neuropsychopharmacology 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3</citedby><cites>FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565082/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5565082/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28783933$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002256441$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshino, Yuta</creatorcontrib><creatorcontrib>Mori, Takaaki</creatorcontrib><creatorcontrib>Yoshida, Taku</creatorcontrib><creatorcontrib>Toyota, Yasutaka</creatorcontrib><creatorcontrib>Shimizu, Hideaki</creatorcontrib><creatorcontrib>Iga, Jun-Ichi</creatorcontrib><creatorcontrib>Nishitani, Shusaku</creatorcontrib><creatorcontrib>Ueno, Shu-Ichi</creatorcontrib><title>Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment</title><title>Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology</title><addtitle>Clin Psychopharmacol Neurosci</addtitle><description>Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven's Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil. Twenty-one DLB patients (mean age, 78.7±4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil. There were significant improvements of RCPM in the total scores between one year donepezil treatment ( =0.013), in both Set A score ( =0.002) and Set AB score ( =0.015), but trend in the Set B score ( =0.083). Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment.</description><subject>Original</subject><subject>정신과학</subject><issn>1738-1088</issn><issn>2093-4327</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkd9u0zAUxi0EYtXYA3CDfAdcJPhv7NwglY5BpSLQVLi1HMfZzBI7s9NO5RH21HPbMYFl6UjnfN_vHOkD4DVGZS24_GBGXxKERYl5SUvC6DMwI6imBaNEPAczLKgsMJLyBJyl9BvlR-uK1fQlOCFSSFpTOgP3y2GMYWsH6ycYOvjLpU0o0qgnp3t4sfFmcsHDeUo2_xY2O3ipt9a_TXAR-hBz60cMVzFP3dbCb3qKztgEnYfnB6jT8M5N13Bl73bwU2hdHmbIefB2tH9cD9fR6mmvfAVedLpP9uyxnoKfF5_Xi6_F6vuX5WK-KgyjdCo6gyin2GDGMGlsWxHBMKUN560VxPJaNF1VVTUmGudeixpuJcENwp0URLf0FLw_cn3s1I1xKmh3qFdB3UQ1v1wvFamYlAxl7cejdtw0g21NPjPqXo3RDTruDs7_J95dZ85WcV5xJEkGvHsExHC7sWlSg0vG9r32NmySwjURFAmGZJbio9TEkFK03dMajNQ-cpUjV_vIFeaKqhx59rz5974nx9-A6QO7rKnw</recordid><startdate>20170831</startdate><enddate>20170831</enddate><creator>Yoshino, Yuta</creator><creator>Mori, Takaaki</creator><creator>Yoshida, Taku</creator><creator>Toyota, Yasutaka</creator><creator>Shimizu, Hideaki</creator><creator>Iga, Jun-Ichi</creator><creator>Nishitani, Shusaku</creator><creator>Ueno, Shu-Ichi</creator><general>Korean College of Neuropsychopharmacology</general><general>대한정신약물학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope></search><sort><creationdate>20170831</creationdate><title>Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment</title><author>Yoshino, Yuta ; Mori, Takaaki ; Yoshida, Taku ; Toyota, Yasutaka ; Shimizu, Hideaki ; Iga, Jun-Ichi ; Nishitani, Shusaku ; Ueno, Shu-Ichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Original</topic><topic>정신과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshino, Yuta</creatorcontrib><creatorcontrib>Mori, Takaaki</creatorcontrib><creatorcontrib>Yoshida, Taku</creatorcontrib><creatorcontrib>Toyota, Yasutaka</creatorcontrib><creatorcontrib>Shimizu, Hideaki</creatorcontrib><creatorcontrib>Iga, Jun-Ichi</creatorcontrib><creatorcontrib>Nishitani, Shusaku</creatorcontrib><creatorcontrib>Ueno, Shu-Ichi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshino, Yuta</au><au>Mori, Takaaki</au><au>Yoshida, Taku</au><au>Toyota, Yasutaka</au><au>Shimizu, Hideaki</au><au>Iga, Jun-Ichi</au><au>Nishitani, Shusaku</au><au>Ueno, Shu-Ichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment</atitle><jtitle>Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology</jtitle><addtitle>Clin Psychopharmacol Neurosci</addtitle><date>2017-08-31</date><risdate>2017</risdate><volume>15</volume><issue>3</issue><spage>243</spage><epage>247</epage><pages>243-247</pages><issn>1738-1088</issn><eissn>2093-4327</eissn><abstract>Donepezil is used to improve cognitive impairment of dementia with Lewy bodies (DLB). Visuo-spatial dysfunction is a well-known symptom of DLB. Non-verbal Raven's Colored Progressive Matrices (RCPM) were used to assess both visual perception and reasoning ability in DLB subjects treated with donepezil. Twenty-one DLB patients (mean age, 78.7±4.5 years) were enrolled. RCPM assessment was performed at the time of starting donepezil and within one year after starting donepezil. There were significant improvements of RCPM in the total scores between one year donepezil treatment ( =0.013), in both Set A score ( =0.002) and Set AB score ( =0.015), but trend in the Set B score ( =0.083). Donepezil is useful for improving visuo-spatial impairment in DLB, but not for problem-solving impairment.</abstract><cop>Korea (South)</cop><pub>Korean College of Neuropsychopharmacology</pub><pmid>28783933</pmid><doi>10.9758/cpn.2017.15.3.243</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1738-1088
ispartof Clinical Psychopharmacology and Neuroscience, 2017, 15(3), , pp.243-247
issn 1738-1088
2093-4327
language eng
recordid cdi_nrf_kci_oai_kci_go_kr_ARTI_2648840
source Freely Accessible Science Journals; PubMed Central
subjects Original
정신과학
title Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T21%3A23%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Improvement%20of%20Visuo-spatial%20Function%20Assessed%20by%20Raven's%20Colored%20Progressive%20Matrices%20in%20Dementia%20with%20Lewy%20Bodies%20by%20Donepezil%20Treatment&rft.jtitle=Clinical%20psychopharmacology%20and%20neuroscience%20:%20the%20official%20scientific%20journal%20of%20the%20Korean%20College%20of%20Neuropsychopharmacology&rft.au=Yoshino,%20Yuta&rft.date=2017-08-31&rft.volume=15&rft.issue=3&rft.spage=243&rft.epage=247&rft.pages=243-247&rft.issn=1738-1088&rft.eissn=2093-4327&rft_id=info:doi/10.9758/cpn.2017.15.3.243&rft_dat=%3Cproquest_nrf_k%3E1927307408%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c433t-fc03531c14412bed6274133b55de72e597bf666912a155dd0b5e821b01f872ad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1927307408&rft_id=info:pmid/28783933&rfr_iscdi=true